Arkadiusz Kuczaj, PhD

Manager Aerosol Research and Dosimetry at Philip Morris International Research and Development

Arkadiusz K. Kuczaj earned his PhD (2006) in the field of Applied Mathematics from the University of Twente, the Netherlands.

As Manager of Aerosol Research and Dosimetry, he is currently leading aerosol delivery and characterization, in vitro exposure, and in vivo inhalation research in the Biomedical Research Department (BMRD) at Philip Morris International R&D (PMI R&D) in Neuchatel, Switzerland. Since 2013 he also holds an Associate Professor position in Industrial Computational Modeling at the Department of Applied Mathematics of the University of Twente. His scientific interests include experimental and computational methods in life-science applications with primary focus on inhalation, novel in vitro methods, and pulmonary delivery.

His work spans from fundamental aerosol dynamics investigations, through development and assessment of novel experimental and computational techniques for characterization of aerosol generation, transport, and delivery in the laboratory systems, to establishment of aerosol dosimetry models ultimately aimed at exposure-dose translations for toxicological risk assessment.

He published and co-authored more than 30 technical manuscripts in the field of life-science, aerosol research, computational physics and fluid dynamics.

Arkadiusz_Kuczaj_Philip_Morris_IRDD_BioTech_Pharma_Summit_Inhalation_Respiratory_Drug_delivery_New_York_Gallery

Accurate dosimetry predictions for evolving liquid aerosol delivery

  • Aerosol evolution as challenge in accurate dosimetry predictions\
  • Aerosol dosimetry requires joint experimental and computational efforts
  • AeroSolved developed as computational fluid dynamics (CFD) package for complex aerosol simulations
  • Linking aerosol dosimetry with physiologically based pharmacokinetic (PBPK) modeling

Other Speakers from the IRDD Summit 2020

Mark Milton-Edwards

Head of Product & Health Solutions at Teva

Diana Fernandes

Inhaled Biopharmaceutical Development Scientist at Hovione

Dino Farina

Founder and CEO at Proveris Scientific